Ausgabe 3/2018
Inhalt (7 Artikel)
IAPP/amylin and β-cell failure: implication of the risk factors of type 2 diabetes
Azuma Kanatsuka, Shigetake Kou, Hideichi Makino
Factors involved in decreasing the therapeutic effect of sitagliptin: a subanalysis of the JAMP study
Hideo Nunome, Hiroshi Sakura, Naotake Hashimoto, Kazuo Sasamoto, Hiroshi Ohashi, Sumiko Hasumi, Noriko Ujihara, Tadasu Kasahara, Osamu Tomonaga, Masashi Honda, Yasuhiko Iwamoto, Akiko Sato, Akira Miyashita, Asako Kokubo, Atsuro Tsuchiya, Dai Hirohara, Daiji Kogure, Daijo Kasahara, Hideki Tanaka, Hideki Tanaka, Hideo Tezuka, Hiroyuki Kuroki, Jun Ogino, Kanu Kin, Kanu Kin, Kazuko Muto, Kazuo Suzuki, Keiko Iseki, Keita Watanabe, Kenshi Higami, Kenzo Matsumura, Kiyotaka Nakajima, Koki Shin, Kuniya Koizumi, Maki Saneshige, Makio Sekine, Makoto Yaida, Mari Kiuchi, Mari Mugishima, Mari Osawa, Masae Banno, Masahiro Yamamoto, Masatake Hiratsuka, Masumi Hosoya, Michika Atsuta, Mitsutoshi Kato, Miwa Morita, Munehiro Miyamae, Mutsumi Iijima, Naomi Okuyama, Nobuo Hisano, Norihiro Tsuchiya, Rie Wada, Rie Wada, Ryuji Momose, Sachiko Otake, Satoko Maruyama, Satoru Takada, Shigeki Dan, Shigeki Nishizawa, Shigeo Yamashita, Shingo Saneshige, Shinichi Teno, Shinji Tsuruta, Shinobu Kumakura, Sumiko Kijima, Takashi Kondo, Takeo Onishi, Taku Kudo, Tatsushi Sugiura, Toshihiko Ishiguro, Yasue Suzuki, Yasuhiro Tomita, Yasuko Takano, Yoshihisa Akimoto, Yoshiko Odanaka, Yoshimasa Tasaka, Yoshitaka Aiso, Yukiko Inoue, Yukinobu Kobayashi
Efficacy and safety of nateglinide plus sitagliptin combination therapy in type 2 diabetes patients inadequately controlled by sitagliptin monotherapy: a phase 3, multicenter, open-label, long-term study
Takahisa Hirose, Chihiro Saitoh, Ichiro Oikawa, Nobuo Kondo
Development of a novel estimation method for hemoglobin A1c using glycated albumin in type 2 diabetes mellitus patients with end-stage renal disease
Akihiko Nakamura, Ryo Kodera, Noriko Sakamoto, Haruyo Ujike, Jun Wada, Kenichi Shikata, Hirofumi Makino
Low body mass index and old age are useful in predicting the hemoglobin A1c-lowering effect of switching from sitagliptin to dulaglutide in Japanese patients with type 2 diabetes mellitus: a single-center, open-label, single-arm, pilot study
Tomoyuki Iwasaki, Takaomi Kessoku, Takuma Higurashi, Masataka Taguri, Masato Yoneda
A case of hyperinsulinemic hypoglycemia related with a calcimimetic agent
Satoru Takashima, Takuma Narita, Hitomi Otomo, Tatsunori Shimizu, Yuichiro Yamada
Effect of switching from conventional continuous subcutaneous insulin infusion to sensor augmented pump therapy on glycemic profile in Japanese patients with type 1 diabetes
Atsuko Matsuoka, Yushi Hirota, Shin Urai, Tetsushi Hamaguchi, Takehito Takeuchi, Hiroshi Miura, Natsu Suematsu, Anna So, Tomoaki Nakamura, Hisako Komada, Yuko Okada, Kazuhiko Sakaguchi, Wataru Ogawa